Skip to content
10-Q

Quarterly Report

BRAINSTORM CELL THERAPEUTICS INC. BCLI

0001410578-25-001782

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 10.38M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 7.49M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.75M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.53M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.5M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$5.13M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.68M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$4.75M
Short Term Debt Q2 2025 · Jun 30, 2025 $101K
Short Term Debt Q2 2025 · Dec 31, 2024 $300K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $824K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $187K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$6.06M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$7.46M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$7.76M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$3.53M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$5.55M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$4.86M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.53M
Current Liabilities Q2 2025 · Dec 31, 2024 $8.98M
Total Liabilities Q2 2025 · Jun 30, 2025 $8.62M
Total Liabilities Q2 2025 · Dec 31, 2024 $9.6M
Current Assets Q2 2025 · Jun 30, 2025 $1.52M
Current Assets Q2 2025 · Dec 31, 2024 $385K
Total Assets Q2 2025 · Jun 30, 2025 $2.57M
Total Assets Q2 2025 · Dec 31, 2024 $1.83M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.77
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.60
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$1.35
Eps Basic Q2 2025 · Jun 30, 2025 −$0.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.77
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.60
Eps Basic restated Q2 2025 · Jun 30, 2024 −$1.35
Sga Expense Q2 2025 · Jun 30, 2025 $1.45M
Sga Expense Q2 2025 · Jun 30, 2025 $3.24M
Sga Expense Q2 2025 · Jun 30, 2024 $2.06M
Sga Expense Q2 2025 · Jun 30, 2024 $3.57M
Rd Expense Q2 2025 · Jun 30, 2025 $1.12M
Rd Expense Q2 2025 · Jun 30, 2025 $2.42M
Rd Expense Q2 2025 · Jun 30, 2024 $922K
Rd Expense Q2 2025 · Jun 30, 2024 $1.88M
Net Income Q2 2025 · Jun 30, 2025 −$2.9M
Net Income Q2 2025 · Jun 30, 2025 −$5.77M
Net Income Q2 2025 · Mar 31, 2025 −$2.86M
Net Income Q2 2025 · Jun 30, 2024 −$2.54M
Net Income Q2 2025 · Jun 30, 2024 −$5.94M
Net Income Q2 2025 · Mar 31, 2024 −$3.4M
Operating Income Q2 2025 · Jun 30, 2025 −$2.57M
Operating Income Q2 2025 · Jun 30, 2025 −$5.66M
Operating Income Q2 2025 · Jun 30, 2024 −$2.98M
Operating Income Q2 2025 · Jun 30, 2024 −$5.46M